Radiation InjuriesRadiation DosageRadiotherapyRadiotherapy DosageRadiation, IonizingDNA DamageDose-Response Relationship, RadiationCombined Modality TherapyRadiation ToleranceRadiotherapy, ConformalRadiotherapy, Intensity-ModulatedRadiation OncologyDose FractionationRadiotherapy, AdjuvantRadiotherapy Planning, Computer-AssistedRadiationBrachytherapyRadiation ProtectionProstatic NeoplasmsRadiation PneumonitisRadiosurgeryNeoplasm Recurrence, LocalRadiation MonitoringTreatment OutcomeNeoplasms, Radiation-InducedBreast NeoplasmsRadiometryNeoplasm StagingRadiotherapy, Computer-AssistedRadiation-Sensitizing AgentsHead and Neck NeoplasmsLung NeoplasmsCranial IrradiationBrain NeoplasmsRetrospective StudiesRadiotherapy, Image-GuidedSurvival AnalysisAntineoplastic Combined Chemotherapy ProtocolsNeoplasmsSurvival RateCarcinoma, Squamous CellParticle AcceleratorsFollow-Up StudiesDisease-Free SurvivalRadiation Injuries, ExperimentalEarly Detection of CancerGamma RaysPrognosisRadiotherapy, High-EnergyOrgans at RiskChemotherapy, AdjuvantRadiodermatitisAntineoplastic AgentsNeoplasm MetastasisChemoradiotherapyAdenocarcinomaRadiation-Protective AgentsTime FactorsCisplatinRectal NeoplasmsTumor BurdenTomography, X-Ray ComputedMastectomy, SegmentalPancreatic NeoplasmsCarcinoma, Non-Small-Cell LungCosmic RadiationProstate-Specific AntigenUterine Cervical NeoplasmsFluorouracilUltraviolet RaysOvarian NeoplasmsMice, NudeNeoplasm InvasivenessCell Line, TumorNeoplasms, Second PrimaryCarcinomaProspective StudiesColonic NeoplasmsDNA RepairCobalt RadioisotopesStomach NeoplasmsCell SurvivalMastectomySEER ProgramActuarial AnalysisDisease ProgressionKaplan-Meier EstimateAndrogen AntagonistsGene Expression Regulation, NeoplasticLymphatic IrradiationApoptosisFour-Dimensional Computed TomographyRisk AssessmentSurvivorsTumor Suppressor Protein p53RiskBackground RadiationRadiobiologyGlioblastomaXenograft Model Antitumor Assays